XRP price today: Ripple-linked token jumps above $2.20 as crypto stocks rise, CoinShares flags inflow surge

XRP price today: Ripple-linked token jumps above $2.20 as crypto stocks rise, CoinShares flags inflow surge

New York, Jan 5, 2026, 13:46 EST — Regular session

  • XRP was up about 7% at $2.23, after trading between $2.07 and $2.23 over the past 24 hours. CoinMarketCap
  • CoinShares said XRP-linked investment products took in $3.7 billion in 2025, part of $47.2 billion of global digital-asset inflows last year. CoinShares Research Blog
  • Coinbase shares were up about 7.4% and Strategy rose about 2.6% in regular U.S. trade.

XRP rose about 7% to $2.23 on Monday, pushing the token associated with payments-focused blockchain firm Ripple back above the $2.20 area as the broader crypto complex advanced. CoinMarketCap

The move matters because traders entered 2026 watching whether early-year risk appetite would spill from bitcoin into more volatile “altcoins” such as XRP. A CoinShares report published on Monday pointed to a rotation toward select tokens via investment products that track crypto prices. CoinShares Research Blog

Macro risk is also back in focus. Traders are looking ahead to the U.S. employment report for December 2025, scheduled for Friday, Jan. 9 at 8:30 a.m. ET, which can reset expectations for interest rates and the dollar. Bureau of Labor Statistics

CoinMarketCap data showed XRP traded between $2.07 and $2.23 in the past 24 hours, with about $4.1 billion in volume over that period and a market value around $135 billion. CoinMarketCap

Other major tokens were higher, keeping the tape broadly supportive. Bitcoin was up about 3% near $94,000 and ether gained about 2% to around $3,200, CoinMarketCap data showed. CoinMarketCap

CoinShares researcher James Butterfill wrote that global digital-asset investment products attracted $47.2 billion in inflows in 2025, just below the 2024 record. “The year also began on a high note with inflows of US$671m last Friday,” he wrote. CoinShares Research Blog

The report said XRP-linked products posted $3.7 billion in inflows in 2025, up 500% year on year, even as bitcoin-linked products slowed. Such investment products include exchange-traded products, which trade like shares and aim to track the price of an underlying asset. CoinShares Research Blog

Crypto’s lift spilled into U.S.-listed equities tied to trading and token prices. Coinbase was up about 7.4% and Strategy rose about 2.6% in regular-session trading.

But the setup is vulnerable to a sharp reversal if rates reprice higher. A stronger U.S. jobs report can lift Treasury yields and the dollar — typically a headwind for speculative assets — while leverage in crypto derivatives can amplify any pullback. Bureau of Labor Statistics

In the background, U.S. data are already flashing mixed signals: the latest Institute for Supply Management survey showed manufacturing activity contracted for a tenth month in December, hitting a 14-month low. The next clear catalyst for XRP and the wider market is Friday’s payrolls release at 8:30 a.m. ET. Reuters

Stock Market Today

  • Intuitive Surgical valuation near fair value after strong run
    January 6, 2026, 8:55 PM EST. Intuitive Surgical (ISRG) appears near its narrative fair value of $596.36, with a last close of $592.85. The gap is small despite a 90-day return of 32.3% and a 5-year TSR of 125.6%. The narrative attributes value to ongoing product innovation-da Vinci 5, integrated force feedback, and AI-driven case insights-that could lift procedure growth, system ASPs, and recurring instrument revenues. Risks include tariff-related margin pressure and tighter hospital budgets in key international markets. The stock's forward P/E at about 76.5x sits well above the Medical Equipment group (≈29.9x) and peers, implying a premium. The question: is that premium justified by the outlook for growth and margins?
Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next
Previous Story

Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next

Structure Therapeutics stock slides nearly 8% as Novo’s Wegovy pill debut jolts oral obesity-drug bets
Next Story

Structure Therapeutics stock slides nearly 8% as Novo’s Wegovy pill debut jolts oral obesity-drug bets

Go toTop